Elimusertib (BAY1895344), a novel ATR inhibitor, demonstrates in vivo activity in ATRX mutated models of uterine leiomyosarcoma
Justin Harold, Stefania Bellone, Diego Manavella, Levent Mutlu, Blair McNamara, Tobias M.P. Hartwich, Margherita Zipponi, Yang Yang‐Hartwich, Cem Demirkiran, Miguel Skyler Z. Verzosa, Jungmin Choi, Weilai Dong, Natália Buza, Pei Hui, Gary Altwerger, Gloria S. Huang, Vaagn Andikyan, Mitchell Clark, Elena Ratner, Masoud Azodi, Peter E. Schwartz, Alessandro D. Santin
Topics & Concepts
ATRXIn vivoMedicineCancer researchEx vivoLeiomyosarcomaInternal medicinePathologyBiologyMutationGeneGeneticsMicrotubule and mitosis dynamicsMultiple Myeloma Research and TreatmentsMelanoma and MAPK Pathways